Hotgen Biotech

Name

Hotgen Biotech

Legal name

Beijing Hotgen Biotech Co., Ltd.

Website

https://hotgenbiotech.com

Company type

Public

Founded year

2005

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

In-Vitro Diagnostics (IVD)

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826), Pharmaceutical Preparations (2834)

akta.pro primary industry

Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing) (HLAAALAH)

akta.pro secondary industries

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)

Keywords

• In-vitro diagnostics
• Chemiluminescence immunoassay
• Diagnostic analyzers
• Point-of-care testing
• Rapid test kits

Headquarters

HQ city

Daxing

HQ country

China

HQ region

Asia

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Operations, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. IVD Diagnostic Products: Revenue from sale of in-vitro diagnostic products including CLIA analyzers (MQ60, C800, C2100), UPT systems, colloidal gold rapid tests, ELISA kits, and test reagents covering 130+ parameters for thyroid, cardiac, tumor, inflammation, and other markers.
2. IVD & Drug Raw Materials: Sale of raw materials for IVD manufacturing and pharmaceutical production including antibodies, antigens, and reagents.
3. Health & Beauty Products: Revenue from EXOMICS skincare series (Edelweiss firming creams, essences, masks) and home beauty instruments (RF anti-aging devices, HIFU devices, IPL hair removal).
4. OEM/ODM Manufacturing Services: B2B strategic cooperation providing design and production of diagnostic hardware, software, and reagents to partners who handle branding, regulatory certification, and distribution.
5. Antibody Medicines: Revenue from FIC (First-in-Class) antibody medicines through subsidiary Sungen Biomed.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels4 records

Core offering

Hotgen Biotech manufactures and sells in-vitro diagnostic (IVD) products including chemiluminescence (CLIA) immunoassay analyzers (MQ60 series, C800, C2100), Up-Converting Phosphor Technology (UPT) POCT analyzers, colloidal gold rapid test kits, ELISA kits, and tuberculosis detection systems, covering 130+ parameters for cardiac, thyroid, tumor, inflammation, infectious disease, and hormone testing. The company also operates a consumer EXOMICS skincare brand and offers OEM/ODM immunoassay analyzer partnership services to global IVD manufacturers.

Product overview

Hotgen Biotech is a Beijing-based biotechnology company (SSE: 688068) founded in 2005, offering a comprehensive IVD product portfolio spanning multiple technology platforms. The core offerings include three CLIA analyzer lines: MQ60 series (MQ60 smart and MQ60 proB) for single-test decentralized testing (30-60 tests/hour), C800 for medium-throughput automated testing (150 tests/hour), and C2100 for high-throughput whole blood testing (200 tests/hour). Supporting these analyzers is a reagent menu covering over 130 parameters including cardiac markers, thyroid function, tumor markers, hormones, inflammation, and infectious diseases. The UPT platform (UPT2800 analyzer with corresponding test kits) provides point-of-care quantitative detection with room temperature storage capability. The company also offers colloidal gold rapid tests and ELISA kits for various applications. Beyond diagnostics, Hotgen operates a consumer Health & Beauty segment through the EXOMICS skincare brand featuring Edelweiss extract-based anti-aging products, and a home beauty instruments line including RF, HIFU, and IPL devices. The company provides OEM/ODM partnership services for global IVD manufacturers seeking customizable diagnostic solutions.

Differentiator

Problem solved

Functional benefit

Brands

• EXOMICS: Science-driven skincare brand under Hotgen Biotech, featuring Edelweiss extract-based anti-aging cosmetic series and skincare products powered by exosome research and biotechnology
• Rejing
• Sungen

Products and services

• MQ60 Series Single-Test Chemiluminescence Immunoassay Analyzers Ultra-compact single-test chemiluminescence immunoassay analyzers for decentralized clinical testing in small to medium laboratories, clinics, and point-of-care settings; supports serum, plasma, and whole blood samples.
• C800 Fully Automated Chemiluminescence Immunoassay Analyzer Compact fully automated CLIA analyzer for medium to large hospitals and central reference laboratories requiring high-throughput immunoassay testing with LIS/HIS connectivity.
• C2100 Fully Automated Whole Blood CLIA Analyzer Third-generation whole blood CLIA platform with up to 200 tests/hour capacity, direct whole blood testing without centrifugation, 50 sample positions, 15 reagent positions, and 12-minute first result time.
• UPT2800 Upconversion Phosphor POCT Analyzer Portable upconversion phosphor technology analyzer providing quantitative results in 20 seconds for cardiac, inflammation, liver, diabetes, hormones, and infectious disease markers with room temperature reagent storage.
• Chemiluminescence Immunoassay (CLIA) Reagent Kits Full portfolio of chemiluminescence immunoassay reagent kits including cardiac, thyroid, tumor, hormone, inflammation, infectious disease, renal function, anemia, liver disease, gastric function, and brain injury test kits.
• Up-Converting Phosphor Technology (UPT) Test Kits UPT-based rapid test kits providing quantitative detection for cardiac, inflammation, liver disease, diabetes, hormones, infectious diseases, and other biomarkers with room temperature storage.
• Colloidal Gold (CG) Immunoassay Rapid Test Kits Rapid point-of-care test kits using colloidal gold technology for qualitative and semi-quantitative detection of cardiac, inflammation, rheumatoid arthritis, infectious disease, and preterm birth markers.
• Enzyme-linked Immunosorbent Assay (ELISA) Kits ELISA diagnostic kits for quantitative detection of tumor markers, liver disease, rheumatoid arthritis, cardiovascular markers, and other biomarkers in clinical laboratory settings.
• Tuberculosis Infection T-Cell Detection System (TB-IGRA) Interferon-gamma release assay (IGRA) system for detection of latent and active tuberculosis infection using whole blood samples with automated processing on CLIA platforms.
• COVID-19 Rapid Test Kit CE-IVD certified rapid antigen detection test kit for COVID-19 delivering results in 15 minutes.
• Mpox (Monkeypox) Virus Rapid Test Kit CE-IVD certified rapid antigen detection test kit for monkeypox virus with 15-minute test time using skin lesion exudate and nasal swabs.
• Dengue Fever Rapid Test Kit Rapid test kit detecting dengue virus NS1 antigen and IgM/IgG antibodies for early screening and confirmation of dengue fever infection.
• EXOMICS Anti-Aging Skincare Series Science-driven skincare line featuring Edelweiss extract-based firming cream, essence toner, emulsion, eye cream, and dual-chamber mask with Pro-Xylane technology for skin firming and wrinkle reduction.
• Home Beauty Instruments Series Home-use beauty devices including RF anti-aging device, HIFU anti-aging device, oxygen injection facial sprayer, LED beauty mask, and IPL hair removal.
• Exo-01 EV MicroRNA Detector (Extracellular Vesicle Diagnostics) Fully automated extracellular vesicle microRNA detector for liquid biopsy applications in cancer diagnostics and disease monitoring.
• OEM/ODM Immunoassay Analyzer Partnership Program B2B strategic cooperation offering design and production of diagnostic hardware, software, and reagents to partners who handle branding, regulatory certification, and global distribution; includes brand customization, label customization, and performance adjustments.
• IVD & Drug Raw Materials Diagnostic and pharmaceutical raw materials including antibodies, antigens, and reagents for IVD manufacturing and drug development.

Quantifiable outcome

• Results available in 17-20 minutes for most tests
• +4 more outcomes

Named customers1 record

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature7 records

Partnerships

Two partnerships are on record, tiered core.

• Rejing BiocoreOEM/ Whitelabel/ Licensing PartnerRejing Bio collaborates with Hotgen for OEM immunoassay analyzer solutions, leveraging Hotgen's manufacturing capabilities and regulatory certifications to provide high-quality diagnostic solutions to global markets.
• Sungen BiomedcoreStrategic or Co-development PartnerSubsidiary focusing on First-in-Class (FIC) antibody medicines, representing Hotgen's expansion from diagnostics into innovative pharmaceutical development.

Scale indicators10 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Beckman Coulter Diagnostics: Beckman Coulter (Access/DxI immunoassay family plus DxH hematology) is a global IVD incumbent with deep reference-lab relationships. Its broad clinical chemistry and immunoassay menus overlap directly with Hotgen's cardiac, thyroid, and infectious disease assay catalogue.
• Roche Diagnostics: Roche is the global IVD market leader (cobas, Elecsys immunoassay platforms) with a deeply entrenched installed base in large hospital and reference labs worldwide. It represents the incumbent competitive benchmark Hotgen's C800/C2100 and reagent menus must unseat in tier-1 international hospital accounts.
• DiaSorin: DiaSorin (LIAISON XL chemiluminescence analyzers) is an Italian-born specialty IVD player with global reach focused on immunoassay menus including infectious disease and vitamin D. DiaSorin competes with Hotgen on CLIA reagents and serves similar mid-size and reference laboratory customers internationally.
• Siemens Healthineers: Siemens Healthineers (Atellica/Advia Centaur immunoassay systems) competes broadly with Hotgen in integrated clinical chemistry and immunoassay automation for central hospital labs. Their automation track (Atellica) directly contests Hotgen's LAS-H2 + C2100 high-throughput positioning.
• Abbott Diagnostics: Abbott operates a global IVD franchise (Architect and Alinity ci-series immunoassay analyzers) plus rapid diagnostics. Comparable to Hotgen as a full-line IVD incumbent with overlapping cardiac, infectious disease, and metabolic test menus on high-throughput platforms.

Direct peers

• YHLO Biotech: YHLO is a Chinese IVD company specializing in chemiluminescence immunoassay analyzers (iFlash series) with strong domestic market share and international expansion. It is one of Hotgen's closest direct competitors in the CLIA hospital segment in China and overseas emerging markets.
• Maccura Biotechnology: Maccura is a Sichuan-based Chinese IVD manufacturer with chemiluminescence (i 3000 series), clinical chemistry, and POCT offerings, plus an established international footprint. Comparable to Hotgen as a Chinese CLIA + reagent house competing in price-sensitive hospital tenders in Asia, Africa, and Latin America.
• Snibe (Shenzhen New Industries Biomedical Engineering): Snibe is the leading Chinese chemiluminescence immunoassay specialist (MAGLUMI series) with deep hospital penetration in China and growing international reach. Snibe directly competes with Hotgen on CLIA reagents, automatic analyzer platforms (Snibe's high-throughput vs. C800/C2100), and Chinese public hospital procurement.
• Mindray: Mindray is China's largest medical device and IVD group with a full chemiluminescence immunoassay line (CL-series analyzers, SAL reagents) sold globally. Both companies are Beijing/Shenzhen-headquartered Chinese IVD manufacturers building overseas through reagent menus, OEM relationships, and large installed analyzer footprints in tier-1 hospital labs.
• Autobio Diagnostics: Autobio is a major Chinese IVD manufacturer (A2000+/A6200 CLIA analyzers, ELISA, chemiluminescence reagents) competing head-to-head with Hotgen in Chinese hospital labs. Both companies target similar menu of thyroid, cardiac, infectious, and tumor markers across CLIA, ELISA, and rapid test formats.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/HotgenChina
• LinkedInlinkedin.com/company/beijing-hotgen-biotech-co-ltd

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hotgen Biotech